Abramson Cancer Center of the University of Pennsylvania — Philadelphia, Pennsylvania

What best describes you?

🧭 Patient, caregiver or referring clinician

This page counts public registry records — it is not a list of trials you can join.

Studies recruiting near Philadelphia →

Never medical advice — always discuss trial participation with your own doctor first.

🏢 I work at this facility, a sponsor or a CRO

Verify and correct how this facility appears in public registry records — free — and open the full registry-entry list below.

Verify this profile →

Public research footprint of Abramson Cancer Center of the University of Pennsylvania, compiled from the ClinicalTrials.gov public registry.

415

Registered studies

54

Active

29

Recruiting now

271

Completed

83

Stopped or withdrawn

Most-studied conditions

Breast Cancer · NSCLC (Non-small Cell Lung Cancer) · Carcinoma, Non-Small-Cell Lung · mCRPC (Metastatic Castration-resistant Prostate Cancer)

Recently updated registry entries

NCT02206984 — Endocrine Response in Women With Invasive Lobular Breast Cancer (Completed)
NCT00265850 — Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients… (Completed)
NCT02798341 — The Breast Program - Translational Cancer Resource (Active Not Recruiting)

7 more recent registry entries at this facility

Research staff — enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Compiled from public registry records (ClinicalTrials.gov) as of August 07, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.